Ask AI
H.R. 2820Became Law

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.

Became Public Law No: 114-104.

Rep. Smith, Christopher H. [R-NJ-4](R-NJ)Sponsor
22 cosponsors8 D14 R
22cosponsors2committees37actions1related bills9subjects
  1. President

    Became Public Law No: 114-104.

  2. BecameLaw36000

    Became Public Law No: 114-104.

  3. President

    Signed by President.

  4. BecameLaw36000

    Signed by President.

  5. Floor

    Presented to President.

  6. President28000

    Presented to President.

  7. ResolvingDifferencesH41931

    Motion to reconsider laid on the table Agreed to without objection.

  8. ResolvingDifferencesH41610

    On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695). (text as House agreed to Senate amendment: CR H9333)

  9. NotUsed19500

    Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695).(text as House agreed to Senate amendment: CR H9333)

  10. ResolvingDifferencesH40142

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.

  11. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and concur in the Senate amendment to H.R. 2820.

  12. ResolvingDifferencesH40140

    Mr. Pitts moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H9333-9335, H9339)

  13. Floor

    Message on Senate action sent to the House.

  14. Floor

    Passed Senate with an amendment by Unanimous Consent. (consideration: CR S8560; text as passed Senate: CR S8560)

  15. Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S8560; text as passed Senate: CR S8560)

  16. Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 311.

  17. Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  18. Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  19. Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  20. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  21. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  22. FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5801)

  23. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5801)

  24. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 2820.

  25. FloorH30000

    Considered under suspension of the rules. (consideration: CR H5801-5804)

  26. FloorH30300

    Mr. Guthrie moved to suspend the rules and pass the bill.

  27. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 183.

  28. CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 114-242.

    Energy and Commerce Committee
  29. Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 114-242.

    Energy and Commerce Committee
  30. Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  31. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  32. Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  33. Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  34. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  35. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  36. IntroReferralIntro-H

    Introduced in House

  37. IntroReferral1000

    Introduced in House

Dec 18, 201549

(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
Dec 9, 201535

(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
Dec 3, 20151

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
Sep 8, 201581

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Stem Cell Therapeutic and Research Reauthorization Act of 2015

(Sec. 2) This bill amends the Stem Cell Therapeutic and Research Act of 2005 to reauthorize the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program through FY2020. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

Jun 18, 2015

Stem Cell Therapeutic and Research Reauthorization Act of 2015

This bill amends the Stem Cell Therapeutic and Research Act of 2005 to reauthorize the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program through FY2020. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

Stem Cell Therapeutic and Research Reauthorization Act of 2015 — Informed